# FDA Inspection 1309376 - OneBlood, Inc. - March 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/5a8084e9-9266-4959-a96d-357e42fcf701
Source feed: FDA_Inspections

> FDA Inspection 1309376 for OneBlood, Inc. on March 26, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309376
- Company Name: OneBlood, Inc.
- Inspection Date: 2026-03-26
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Florida District Office

## Related Documents

- [FDA Inspection 1121342 - 2020-02-06](https://www.keypedia.com/records/fda_inspections/oneblood-inc/8877fd66-7eb4-43cb-abeb-7d10acaea61b)
- [FDA Inspection 1035764 - 2017-11-14](https://www.keypedia.com/records/fda_inspections/oneblood-inc/9e90ff7e-7ab7-436c-bdf6-de8d37e9760b)
- [FDA Inspection 987798 - 2016-08-02](https://www.keypedia.com/records/fda_inspections/oneblood-inc/e895fa92-dcad-486d-8060-f3053fe89f5f)
- [FDA Inspection 893894 - 2014-08-26](https://www.keypedia.com/records/fda_inspections/oneblood-inc/1dfe3b65-01e1-4bac-9446-e48dff5c7294)
- [FDA Inspection 807212 - 2012-11-16](https://www.keypedia.com/records/fda_inspections/oneblood-inc/e47ed30d-f6a6-4975-9032-ee668689381f)

Company: https://www.keypedia.com/companies/oneblood-inc/f0744635-fe27-4f79-b568-ebe3368db885

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9